Evidence map›Paper›PMID 17626101›Full record

Trial reportJournal of virology2007

Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes.

Allison Imrie, Janet Meeks, Alexandra Gurary, Munkhzul Sukhbataar, Paul Kitsutani, Paul Effler, Zhengshan Zhao

Open access · greenAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. T Cell Responses During Dengue Infection.Current topics in microbiology and immunology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. CD4 T cell responses to flaviviruses.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2018
    Review
  12. Article
  13. Review
  14. Development of Peptide Vaccines in Dengue.Current pharmaceutical design · 2018
    Review
  15. Article
  16. Dengue virus-reactive CD8Nature communications · 2017
    Article
  17. Article
  18. CD4Immunology · 2017
    Review
  19. Mapping and Role of the CD8Cell host & microbe · 2017
    Article
  20. Global Assessment of Dengue Virus-Specific CD4Frontiers in immunology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Allison ImrieDepartment of Public Health Sciences, John A. Burns School of Medicine, 651 Ilalo Street, Honolulu, HI 96813, USA. imrie@pbrc.hawaii.edu
Janet Meeks
Alexandra Gurary
Munkhzul Sukhbataar
Paul Kitsutani
Paul Effler
Zhengshan Zhao
University of Hawaiʻi at Mānoa · USHawaii Department of Health · US

Funding

UHI COBRE: P3: GROUP A STREPT IN RELATION TO ACUTE RHEUMATIC FEVER IN HAWAIIP20RR018727 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI HOANG, TUNG T · 2003 to 2011
$13.8M
NCRR NIH HHS P20 RR 018727NCRR NIH HHS P20 RR018727
6 · The paper itself

Abstract

Proinflammatory cytokines secreted by memory CD8+ and CD4+ T cells are thought to play a direct role in the pathogenesis of dengue virus infection by increasing vascular permeability and thereby inducing the pathophysiologic events associated with dengue hemorrhagic fever and dengue shock syndrome. Severe disease is frequently observed in the setting of secondary infection with heterologous dengue virus serotypes, suggesting a role for cross-reactive memory T cells in the immunopathogenesis of severe disease. We used a large panel of well-characterized dengue virus-specific CD8+ T-cell clones isolated from Pacific Islanders previously infected with dengue virus 1 to examine effector memory function, focusing on a novel dominant HLA-B*5502-restricted NS5(329-337) epitope, and assessed T-cell responses to stimulation with variant peptides representing heterologous serotypes. Variant peptides were differentially recognized by dengue virus 1-specific effector CD8+ cytotoxic T lymphocytes (CTL) in a heterogeneous and clone-specific manner, in which cytolytic function and cytokine secretion could be enhanced, diminished, or abrogated compared with cognate peptide stimulation. Dengue virus-specific CTL stimulated with cognate and variant peptides demonstrated a cytokine response hierarchy of gamma IFN (IFN-gamma) > tumor necrosis factor alpha (TNF-alpha) > interleukin-2 (IL-2), and a subset of clones also produced IL-4 and IL-6. Individual clones demonstrated greater avidity for variant peptides representing heterologous serotypes, including serotypes previously encountered by the subject, and IFN-gamma and TNF-alpha secretion was enhanced by stimulation with these heterologous peptides. Altered antiviral T-cell responses in response to stimulation with heterologous dengue virus serotypes have implications for control of virus replication and for disease pathogenesis.

Indexed as

Immunologic MemoryCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCross ReactionsCytokinesDengue VirusFemaleHawaiiHLA-B AntigensHumansInflammationMalePeptidesSevere DengueViral ProteinsVirus ReplicationCytokinesHLA-B AntigensPeptidesViral Proteins

Identifiers

PMID17626101
PMCPMC2045385
OpenAlexW2118506385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.